NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 273 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,078,543 | -9.4% | 366,153 | +2.7% | 0.00% | 0.0% |
Q1 2024 | $5,607,103 | -2.8% | 356,686 | +0.0% | 0.00% | 0.0% |
Q4 2023 | $5,769,982 | +32.0% | 356,612 | +0.3% | 0.00% | -50.0% |
Q3 2023 | $4,371,176 | -24.9% | 355,380 | -1.9% | 0.00% | 0.0% |
Q2 2023 | $5,823,704 | -8.9% | 362,396 | -1.3% | 0.00% | 0.0% |
Q1 2023 | $6,393,491 | +90.3% | 367,231 | +1.0% | 0.00% | +100.0% |
Q4 2022 | $3,359,574 | +10.1% | 363,590 | +2.6% | 0.00% | 0.0% |
Q3 2022 | $3,052,000 | +5.3% | 354,480 | -0.3% | 0.00% | 0.0% |
Q2 2022 | $2,898,000 | -46.5% | 355,543 | -20.3% | 0.00% | -50.0% |
Q1 2022 | $5,417,000 | -63.1% | 445,868 | +3.6% | 0.00% | -50.0% |
Q4 2021 | $14,685,000 | -22.6% | 430,382 | +9.5% | 0.00% | -33.3% |
Q3 2021 | $18,963,000 | +14.8% | 393,100 | +7.5% | 0.01% | 0.0% |
Q2 2021 | $16,519,000 | -22.2% | 365,719 | -16.9% | 0.01% | -25.0% |
Q1 2021 | $21,221,000 | +5.6% | 439,988 | +17.9% | 0.01% | 0.0% |
Q4 2020 | $20,090,000 | +51.5% | 373,149 | +3.8% | 0.01% | +33.3% |
Q3 2020 | $13,258,000 | +20.7% | 359,386 | +1.3% | 0.01% | +20.0% |
Q2 2020 | $10,988,000 | +23.9% | 354,671 | +10.6% | 0.01% | 0.0% |
Q1 2020 | $8,867,000 | +3.4% | 320,787 | +9.5% | 0.01% | +25.0% |
Q4 2019 | $8,572,000 | +64.3% | 293,057 | +7.4% | 0.00% | +33.3% |
Q3 2019 | $5,218,000 | -1.0% | 272,854 | +13.6% | 0.00% | 0.0% |
Q2 2019 | $5,271,000 | +16.0% | 240,232 | +8.2% | 0.00% | 0.0% |
Q1 2019 | $4,545,000 | +2909.9% | 222,103 | +1756.4% | 0.00% | – |
Q4 2018 | $151,000 | -6.8% | 11,964 | +13.3% | 0.00% | – |
Q3 2018 | $162,000 | +29.6% | 10,559 | +10.0% | 0.00% | – |
Q2 2018 | $125,000 | +52.4% | 9,596 | -4.5% | 0.00% | – |
Q1 2018 | $82,000 | -32.8% | 10,052 | -26.7% | 0.00% | – |
Q4 2017 | $122,000 | -28.7% | 13,710 | -10.8% | 0.00% | – |
Q3 2017 | $171,000 | +42.5% | 15,376 | +16.3% | 0.00% | – |
Q2 2017 | $120,000 | +16.5% | 13,224 | 0.0% | 0.00% | – |
Q1 2017 | $103,000 | -11.2% | 13,224 | -2.2% | 0.00% | – |
Q4 2016 | $116,000 | +100.0% | 13,516 | +83.6% | 0.00% | – |
Q3 2016 | $58,000 | 0.0% | 7,360 | 0.0% | 0.00% | – |
Q2 2016 | $58,000 | +56.8% | 7,360 | +32.7% | 0.00% | – |
Q1 2016 | $37,000 | – | 5,545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |